Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis
Olmedo W, Villablanca P, Sanina C, Walker J, Weinreich M, Brevik J, Avendano R, Bravo C, Romero J, Ramakrishna H, Babaev A, Attubato M, Hernandez-Suarez D, Cox-Alomar P, Pyo R, Krishnan P, Wiley J. Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis. Vascular 2018, 27: 78-89. PMID: 30501582, DOI: 10.1177/1708538118807522.Peer-Reviewed Original ResearchConceptsPercutaneous peripheral interventionsAccess site complicationsPeripheral interventionsCause mortalitySite complicationsMinor bleedingSystematic reviewEfficacy of bivalirudinProcedural anticoagulant agentLarge randomized trialsSignificant differencesBivalirudin useMajor bleedingIntracranial bleedingBlood transfusionRandomized trialsMyocardial infarctionAnticoagulant agentsClinical studiesBivalirudinBleedingComplicationsPatientsHeparinMortalityOesophageal Injury During AF Ablation: Techniques for Prevention.
Romero J, Avendano R, Grushko M, Diaz J, Du X, Gianni C, Natale A, Biase L. Oesophageal Injury During AF Ablation: Techniques for Prevention. Arrhythmia & Electrophysiology Review 2018, 7: 24-31. PMID: 29636969, PMCID: PMC5889811, DOI: 10.15420/aer.2017.46.2.Peer-Reviewed Original ResearchPulmonary vein isolationOesophageal injuryAtrio-oesophageal fistulaPVI procedureMajor morbidityAF ablationVein isolationAtrial fibrillationCommon arrhythmiaRisk factorsLeft atriumPosterior wallInjury preventionInjuryFistulaArrhythmiasPreventionReview articleAblationMorbidityErythemaFibrillationEsophagusAtriumMortality